VTRS
VIATRIS INC
CUSIP: 92556V106
About
Viatris Inc. is a global healthcare company formed through the merger of Mylan and Pfizer’s Upjohn business, focusing on providing access to medicines across the brand, generic, and biosimilars sectors. The company operates one of the industry’s largest and most diverse portfolios, utilizing its global manufacturing and commercial scale to serve patients in over 165 countries. Viatris aims to bridge gaps in healthcare delivery by combining its extensive product lineup with a strategic emphasis on emerging markets and key therapeutic areas.